FR1511M - Mouveau medicament useful in particular for the treatment of hyperchlorhydria, peptic ulcers and colitis caused by fermentation and putrefaction. - Google Patents

Mouveau medicament useful in particular for the treatment of hyperchlorhydria, peptic ulcers and colitis caused by fermentation and putrefaction.

Info

Publication number
FR1511M
FR1511M FR873641A FR873641A FR1511M FR 1511 M FR1511 M FR 1511M FR 873641 A FR873641 A FR 873641A FR 873641 A FR873641 A FR 873641A FR 1511 M FR1511 M FR 1511M
Authority
FR
France
Prior art keywords
mouveau
hyperchlorhydria
putrefaction
fermentation
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR873641A
Other languages
French (fr)
Inventor
Lucien Harnist
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR873641A priority Critical patent/FR1511M/en
Application granted granted Critical
Publication of FR1511M publication Critical patent/FR1511M/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00Silicon; Compounds thereof
    • C01B33/20Silicates
    • C01B33/26Aluminium-containing silicates, i.e. silico-aluminates
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00Silicon; Compounds thereof
    • C01B33/20Silicates
    • C01B33/36Silicates having base-exchange properties but not having molecular sieve properties
    • C01B33/38Layered base-exchange silicates, e.g. clays, micas or alkali metal silicates of kenyaite or magadiite type
    • C01B33/40Clays
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00Silicon; Compounds thereof
    • C01B33/20Silicates
    • C01B33/36Silicates having base-exchange properties but not having molecular sieve properties
    • C01B33/38Layered base-exchange silicates, e.g. clays, micas or alkali metal silicates of kenyaite or magadiite type
    • C01B33/42Micas ; Interstratified clay-mica products
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00Silicon; Compounds thereof
    • C01B33/20Silicates
    • C01B33/36Silicates having base-exchange properties but not having molecular sieve properties
    • C01B33/46Amorphous silicates, e.g. so-called "amorphous zeolites"

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Geology (AREA)
FR873641A 1961-09-18 1961-09-18 Mouveau medicament useful in particular for the treatment of hyperchlorhydria, peptic ulcers and colitis caused by fermentation and putrefaction. Expired FR1511M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR873641A FR1511M (en) 1961-09-18 1961-09-18 Mouveau medicament useful in particular for the treatment of hyperchlorhydria, peptic ulcers and colitis caused by fermentation and putrefaction.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR873641A FR1511M (en) 1961-09-18 1961-09-18 Mouveau medicament useful in particular for the treatment of hyperchlorhydria, peptic ulcers and colitis caused by fermentation and putrefaction.

Publications (1)

Publication Number Publication Date
FR1511M true FR1511M (en) 1962-10-01

Family

ID=87760744

Family Applications (1)

Application Number Title Priority Date Filing Date
FR873641A Expired FR1511M (en) 1961-09-18 1961-09-18 Mouveau medicament useful in particular for the treatment of hyperchlorhydria, peptic ulcers and colitis caused by fermentation and putrefaction.

Country Status (1)

Country Link
FR (1) FR1511M (en)

Similar Documents

Publication Publication Date Title
CA607440A (en) Treatment of sewage
FR1511M (en) Mouveau medicament useful in particular for the treatment of hyperchlorhydria, peptic ulcers and colitis caused by fermentation and putrefaction.
FR126M (en) New drug, in particular for the treatment of postprandial or chronic hyperlipemia.
FR1878M (en) New polysaccharide, usable in therapy, in particular for the treatment of solid tumors.
FR1204M (en) New drug, in particular for the treatment of chronic or post-prandial hyperlipemia.
FR1982M (en) New n-substituted alkanamides-hydrazines, which can be used in particular in the treatment of persistent staphylococcal infections.
FR1731M (en) New amino-pyrazole which can be used in therapy, in particular as a drug for the treatment of inflammatory conditions.
FR3392M (en) Dermatological medicinal product, in particular for the treatment of oozing eczema.
FR363M (en) New drug for the treatment of trypanosomosis, salmonellosis and penicillofacial infections.
FR1456M (en) New drug in particular for the treatment of deficiencies of the corpus luteum.
FR385M (en) New drug for the treatment of staphylococcal infections and the like.
FR1412M (en) New drug in particular for the treatment of bronchitis, pneumonia, heart collapse and heart failure.
FR1804M (en) New drug in particular for the treatment of infections of microbial origin.
FR1729M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR1288M (en) New drug, in particular for the treatment of postprandial or acute hyperlipemia.
FR3881M (en) Medicament useful in particular for the treatment of tuberculosis.
FR1856M (en) New amino-pyrazole which can be used in therapy, in particular as a drug for the treatment of inflammatory conditions.
FR1224M (en) Homeoflora treatment of the sebaceous glands.
FR1510M (en) New drug in particular for the treatment of deficiencies of the corpus luteum.
FR33F (en) New drug for the treatment of staphylococcal infections and the like.
FR1229M (en) Homeoflora treatment of tracheitis.
BE630069A (en) Therapeutic composition for the treatment of parkinsonism.
FR36M (en) New drug, in particular for the treatment of postprandial or acute hyperlipemia.
AU236340B2 (en) Improvements in or relating tothe treatment of sewage
AU247053B2 (en) Treatment of liquids